We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$57.5B
AUM Growth
-$5.08B
Cap. Flow
-$2.38B
Cap. Flow %
-4.14%
Top 10 Hldgs %
15.58%
Holding
3,062
New
102
Increased
955
Reduced
1,409
Closed
325

Sector Composition

Rank Sector Weight
1 Technology 19.8%
2 Financials 14.03%
3 Healthcare 12.94%
4 Consumer Discretionary 9.46%
5 Real Estate 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIOT
2626
Viomi Technology
VIOT
$49.6M
$13K ﹤0.01%
7,311
JNCE
2627
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$13K ﹤0.01%
2,017
ABUS icon
2628
Arbutus Biopharma
ABUS
$923M
$12K ﹤0.01%
4,120
NVTA
2629
DELISTED
Invitae Corporation
NVTA
$12K ﹤0.01%
1,618
-12,219
-88% -$123K
SRGA
2630
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$12K ﹤0.01%
1,417
FDMT icon
2631
4D Molecular Therapeutics
FDMT
$600M
$11K ﹤0.01%
742
-56,197
-99% -$883K
IDYA icon
2632
IDEAYA Biosciences
IDYA
$3.55B
$11K ﹤0.01%
1,008
TGTX icon
2633
TG Therapeutics
TGTX
$7.64B
$11K ﹤0.01%
1,159
-36,884
-97% -$427K
APPN icon
2634
Appian
APPN
$2.54B
$10K ﹤0.01%
175
-9,953
-98% -$565K
LCTX icon
2635
Lineage Cell Therapeutics
LCTX
$283M
$10K ﹤0.01%
6,964
VTGN icon
2636
VistaGen Therapeutics
VTGN
$11.9M
$10K ﹤0.01%
277
EPZM
2637
DELISTED
Epizyme, Inc
EPZM
$10K ﹤0.01%
8,900
-77,039
-90% -$126K
HNP
2638
DELISTED
Huaneng Power Intl, Inc.
HNP
$10K ﹤0.01%
605
-3,933
-87% -$83.5K
VIVS
2639
VivoSim Labs
VIVS
$1.23M
$9K ﹤0.01%
210
SYRS
2640
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$9K ﹤0.01%
904
-51
-5% -$912
BFX
2641
DELISTED
BowFlex Inc.
BFX
$9K ﹤0.01%
2,418
ACOR
2642
DELISTED
Acorda Therapeutics
ACOR
$9K ﹤0.01%
300
FUTU icon
2643
Futu Holdings
FUTU
$14.7B
$8K ﹤0.01%
256
WES icon
2644
Western Midstream Partners
WES
$19.9B
$8K ﹤0.01%
348
-33,295
-99% -$821K
XBIT icon
2645
XBiotech
XBIT
$71M
$8K ﹤0.01%
1,023
LGF.B
2646
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$8K ﹤0.01%
559
-167
-23% -$2.42K
LCI
2647
DELISTED
Lannett Company, Inc.
LCI
$8K ﹤0.01%
2,800
NERV icon
2648
Minerva Neurosciences
NERV
$206M
$7K ﹤0.01%
1,175
PACB icon
2649
Pacific Biosciences
PACB
$354M
$7K ﹤0.01%
793
-98,099
-99% -$1.13M
PHAT icon
2650
Phathom Pharmaceuticals
PHAT
$688M
$7K ﹤0.01%
575
-8,788
-94% -$142K

Similar funds

Russell Investments Group's Q1 2022 Portfolio in Review

As of Q1 2022, Russell Investments Group held 3,062 positions worth $57.5B, down 8.1% from $62.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Russell Investments Group withdrew a net $2.38B in Q1 2022, closing 325 positions and reducing 1,409 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Russell Investments Group opened a new position in Sunstone Hotel Investors worth $17.4M.

  • Russell Investments Group's largest Q1 2022 buy was Sunstone Hotel Investors: 1,471,353 shares worth $17.4M.
  • Russell Investments Group added most to Public Storage in Q1 2022, an estimated $121M increase.
  • Russell Investments Group's biggest Q1 2022 reduction was Extra Space Storage, cutting an estimated $107M.
  • Russell Investments Group fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $124M.
  • Russell Investments Group's ten largest holdings make up 16% of its $57.5B portfolio in Q1 2022.
  • Russell Investments Group opened 102 new positions and closed 325 in Q1 2022.
  • Russell Investments Group's portfolio value fell 8.1% quarter-over-quarter to $57.5B.

Based on Russell Investments Group's 13F filing for Q1 2022, filed 5 May 2022.